PDCD1 and plasma cell myeloma: PD-1 is overexpressed on T cells and natural killer (NK) cells of MM patients, and the PD-1/PD-L1 interaction can disrupt the effective anti-myeloma cell immune response and lead to severe immunosuppression and drug resistance [51].